12:00 AM
 | 
Aug 06, 2012
 |  BC Week In Review  |  Company News  |  Other News

Trophos neurology news

Trophos concluded the three-year MitoTarget project, an EU-funded consortium of 17 academic and research partners to research the use of mitochondrial-targeted molecules to treat neurodegenerative diseases. In 2008, the European Commission awarded a three-year grant of about €6 million ($8.7 million) to the consortium's MitoTarget project...

Read the full 208 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >